RNA evidence supports clinical stage antibody drug targets in oncology
Daniele Pozzobon, Nichal Khusial, Roberto Spreafico, Attila Csala
The paper evaluates whether single-cell RNA-seq improves the prioritization of antibody-based oncology targets by combining tumor specificity, normal safety, and blood sink features.
bioRxiv · Oct 13, 2026 · PreprintBioinformatics